Antidiabetic and Hypolipidemic Efficacy of Glu-NK Decoction in a High-fat Diet and Streptozotocin-induced Mouse Model of Type 2 Diabetes

Background: Type 2 Diabetes Mellitus (T2DM) is a global metabolic disorder demanding effective and safe therapeutic strategies. Polyherbal formulations offer a promising multi-target approach. Aim: To evaluate the hypoglycemic efficacy and metabolic effects of Glu-NK in a High-Fat Diet (HFD) and streptozotocin (STZ)-induced T2DM mouse model. Methods: Swiss albino mice received HFD with fructose supplementation for 8 weeks, followed by low-dose STZ (100 mg/kg, i.p.) to induce T2DM. Diabetic mice were randomly assigned to receive distilled water (model control), glibenclamide (15 mg/ kg/day), or Glu-NK at 96 or 48 mL/kg/day for 2 weeks. Results: Both Glu-NK doses significantly reduced fasting blood glucose levels after 2 weeks, with the higher dose (96 mL/kg/day) demonstrating effects comparable to glibenclamide (p < 0.001 vs. model control). Glu-NK treatment significantly decreased total cholesterol and LDL-cholesterol (p < 0.05 to p < 0.01) and increased hepatic glutathione levels (p < 0.05 to p < 0.001) compared to diabetic controls. A favourable trend toward improvements in HDL-cholesterol and pancreatic oxidative stress parameters was observed. However, hepatorenal function markers (AST, ALT, creatinine, urea) and histopathological features showed no significant improvement after 2 weeks of treatment. Major Finding: These findings suggest that while Glu-NK holds potential as a complementary metabolic therapy, longer treatment durations are required to facilitate meaningful tissue recovery. Further studies are warranted to evaluate its long-term tissue-protective efficacy and mechanisms of action

View article page

Download PDF